Physician profile
John Buckner
NPI 1497797625
$642.49
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.15 · 2020: $116 · 2021: $41.99 · 2022: $38.97 · 2023: $128 · 2024: $104 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.22 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $180.40 | 2021-2024 | Myrisk |
| Dilon Technologies, INC. | $109.09 | 2025 | Hemoblast Bellows |
| Bioptics, INC. | $92.25 | 2020 | |
| Elucent Medical | $45.04 | 2021-2025 | |
| Acera Surgical, INC. | $42.89 | 2025 | Restrata Wound Matrix |
| Advanced Accelerator Applications | $26.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.83 | 2023 | Keytruda, Lynparza |
| Hologic Sales and Service, LLC | $21.09 | 2024 | Trunode, Biozorb |
| Bard Peripheral Vascular, INC. | $20.65 | 2024 | Encor |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Kub Technologies INC. | $17.93 | 2024 | |
| B. Braun Interventional Systems INC. | $17.24 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.26 | 2025 | Exparel |
| Coopersurgical, INC. | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Buckner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.